Ranibizumab
id:
ranibizumab-183-18176716
title:
Ranibizumab
text:
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degeneration, diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. Ranibizumab was developed by Genentech and marketed by them in the United States, and elsewhere by Novartis, under the bran
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Ranibizumab
date created:
2006-07-30T23:09:55Z
date modified:
2024-09-07T04:35:52Z
main entity:
{"identifier":"Q414270","url":"https://www.wikidata.org/entity/Q414270"}
image:
fields total:
13
integrity:
15